carcinoma in situ


Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to carcinoma in situ: squamous cell carcinoma
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for carcinoma in situ

a cluster of malignant cells that has not yet invaded the deeper epithelial tissue or spread to other parts of the body

Related Words

References in periodicals archive ?
Lobular carcinoma in situ most often involves lobules but may also grow along the basement of extralobular ducts, that is, "pagetoid" growth, and may secondarily involve benign lesions, such as radial scars, papillomas, fibroadenomas, and collagenous spherulosis.
Ductal Carcinoma in Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes.
We observed a significant decrease in E-cadherin membrane expression from dysplasia to carcinoma in situ to invasive carcinoma and a significant increase in vimentin expression with progression of the tumor.
As an unintended consequence, screening for invasive breast cancer has resulted in a marked increase in the diagnosis of asymptomatic ductal carcinoma in situ.
Kane, "Ductal carcinoma in Situ of the breast: a systematic review of incidence, treatment, and outcomes," Journal of the National Cancer Institute, vol.
Women are regularly screened from their twenties for carcinoma in situ of the cervix in order to detect this condition early.
Ductal carcinoma in situ is not cancer, so why are we calling it cancer?
The purpose of this article is to discuss two types of breast carcinoma in situ.
Ductal carcinoma in situ (DCIS), which is also known as intraductal carcinoma, is breast cancer in the lining of the milk ducts that has not yet invaded nearby tissues.
Carcinoma in situ (CIS) of the bladder poses a clinical challenge to urologists worldwide.
In the classification of these lesions revealed three main groups-intraductal hyperplasia (IDH), atypical intraductal hyperplasia (AIDH) and ductal carcinoma in situ (DCIS) have been proposed.
For example, treatment for lobular carcinoma in situ (LC1S) does not generally include surgical resection.
Of those women, 83 percent had invasive cancer, 12 percent had carcinoma in situ (localized), and 5 percent had both conditions.
In a randomised, placebo-controlled, double-blind trial of exemestane in Canada, USA, Spain and France, eligible post-menopausal women over 35 years old had at least one of the following risk factors: 60 years of age or older, prior atypical ductal or lobular hyperplasia or lobular carcinoma in situ, or ductal carcinoma in situ with mastectomy.